Skip to main content
. 2017 Mar 10;44(1):87–95. doi: 10.1007/s00068-017-0767-9

Fig. 4.

Fig. 4

a TGF β-1 concentration within the different experimental PRF-based matrices 1 h after clotting. b TGF β-1 concentration within the different experimental PRF-based matrices 24 h after clotting. c Accumulated TGF β-1 concentration within the different experimental PRF-based matrices over 24 h